[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of recombinant human apoptosis-inducing factor 2 ligand for the treatment of advanced non-small cell lung cancer
观察和评价注射用重组人凋亡素2配体对晚期复治非小细胞肺癌患者的有效性和安全性
[Translation] To observe and evaluate the efficacy and safety of recombinant human apoptosis-2 ligand for injection in patients with advanced recurrent non-small cell lung cancer